Dora Kholodenko

12.5k total citations · 3 hit papers
10 papers, 3.9k citations indexed

About

Dora Kholodenko is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Dora Kholodenko has authored 10 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 4 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Dora Kholodenko's work include Alzheimer's disease research and treatments (10 papers), Prion Diseases and Protein Misfolding (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Dora Kholodenko is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Prion Diseases and Protein Misfolding (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Dora Kholodenko collaborates with scholars based in United States, Canada and Germany. Dora Kholodenko's co-authors include Eliezer Masliah, Kang Hu, Lisa McConlogue, Lennart Mucke, Gwen Tatsuno, Kelly Johnson‐Wood, Edward Rockenstein, Gui-Qiu Yu, Margaret Mallory and Peter Seubert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Dora Kholodenko

10 papers receiving 3.8k citations

Hit Papers

High-Level Neuronal Expression of Aβ1–42in Wild-Type Huma... 1995 2026 2005 2015 2000 1999 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
    2000 1.5k citations Lennart Mucke, Eliezer Masliah et al. Journal of Neuroscience profile →
  2. Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
    1999 927 citations Eliezer Masliah, Lisa McConlogue et al. Proceedings of the National Academy of Sciences profile →
  3. Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
    1995 568 citations Ruth Motter, Carmen Vigo‐Pelfrey et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora Kholodenko United States 7 3.3k 1.3k 1.2k 797 753 10 3.9k
Kelly Johnson‐Wood United States 14 3.5k 1.1× 1.6k 1.2× 1.0k 0.9× 853 1.1× 839 1.1× 17 4.1k
Thierry Bussière United States 21 3.0k 0.9× 1.6k 1.2× 922 0.8× 720 0.9× 813 1.1× 29 4.1k
Mark R. Emmerling United States 35 3.3k 1.0× 1.9k 1.5× 674 0.6× 878 1.1× 926 1.2× 63 5.0k
Christine Stürchler-Pierrat Switzerland 18 3.1k 0.9× 1.6k 1.2× 1.0k 0.9× 665 0.8× 733 1.0× 21 3.9k
Gui-Qiu Yu United States 10 2.9k 0.9× 1.2k 0.9× 1.5k 1.3× 797 1.0× 666 0.9× 10 3.7k
Steven G. Younkin United States 22 4.2k 1.3× 2.1k 1.6× 1.0k 0.9× 997 1.3× 958 1.3× 30 5.0k
Leigh A. Holcomb United States 16 2.5k 0.8× 1.3k 1.0× 1.0k 0.9× 836 1.0× 623 0.8× 20 3.7k
Takeshi Kawarabayashi Japan 31 4.1k 1.2× 2.2k 1.7× 1.3k 1.1× 889 1.1× 1.0k 1.4× 129 5.7k
Dieder Moechars Belgium 38 2.7k 0.8× 1.8k 1.4× 1.3k 1.1× 800 1.0× 395 0.5× 67 4.5k
Fengrong Yan United States 11 3.0k 0.9× 1.3k 1.0× 1.3k 1.1× 679 0.9× 1.4k 1.8× 11 4.1k

Countries citing papers authored by Dora Kholodenko

Since Specialization
Citations

This map shows the geographic impact of Dora Kholodenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Kholodenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Kholodenko more than expected).

Fields of papers citing papers by Dora Kholodenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Kholodenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Kholodenko. The network helps show where Dora Kholodenko may publish in the future.

Co-authorship network of co-authors of Dora Kholodenko

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Kholodenko. A scholar is included among the top collaborators of Dora Kholodenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Kholodenko. Dora Kholodenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schroeter, Sally, Elizabeth Brigham, Ruth Motter, et al.. (2010). P3‐321: APP‐selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_18). 3 indexed citations
2.
3.
Seubert, Peter, Robin Barbour, Karen Khan, et al.. (2008). Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse. Neurodegenerative Diseases. 5(2). 65–71. 55 indexed citations
4.
Mucke, Lennart, Eliezer Masliah, Gui-Qiu Yu, et al.. (2000). High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience. 20(11). 4050–4058. 1543 indexed citations breakdown →
5.
Masliah, Eliezer, Lisa McConlogue, Gui-Qiu Yu, et al.. (1999). Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proceedings of the National Academy of Sciences. 96(6). 3228–3233. 927 indexed citations breakdown →
6.
Galasko, Douglas, L. Chang, Ruth Motter, et al.. (1998). High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype. Archives of Neurology. 55(7). 937–937. 369 indexed citations
7.
Qiu, Wei Qiao, Zhen Ye, Dora Kholodenko, Peter Seubert, & Dennis J. Selkoe. (1997). Degradation of Amyloid β-Protein by a Metalloprotease Secreted by Microglia and Other Neural and Non-neural Cells. Journal of Biological Chemistry. 272(10). 6641–6646. 156 indexed citations
8.
Xia, Weiming, Jimin Zhang, Dora Kholodenko, et al.. (1997). Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins. Journal of Biological Chemistry. 272(12). 7977–7982. 243 indexed citations
9.
Schenk, Dale, Ruth Motter, Dora Kholodenko, Ivan Lieberburg, & Peter Seubert. (1996). 2 Aβ42 and Tau as Markers of Alzheimer's Disease. Neurobiology of Aging. 17(4). S1–S1. 3 indexed citations
10.
Motter, Ruth, Carmen Vigo‐Pelfrey, Dora Kholodenko, et al.. (1995). Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 38(4). 643–648. 568 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Johnson‐Wood Breakdown of academic impact, for papers by Thierry Bussière Breakdown of academic impact, for papers by Mark R. Emmerling Breakdown of academic impact, for papers by Christine Stürchler-Pierrat Breakdown of academic impact, for papers by Gui-Qiu Yu Breakdown of academic impact, for papers by Steven G. Younkin Breakdown of academic impact, for papers by Leigh A. Holcomb Breakdown of academic impact, for papers by Takeshi Kawarabayashi Breakdown of academic impact, for papers by Dieder Moechars Breakdown of academic impact, for papers by Fengrong Yan
Rankless by CCL
2026